Skip to Content

Lastacaft Approval History

  • FDA approved: Yes (First approved July 28th, 2010)
  • Brand name: Lastacaft
  • Generic name: alcaftadine
  • Dosage form: Ophthalmic Solution
  • Company: Allergan plc
  • Treatment for: Conjunctivitis, Allergic

Lastacaft (alcaftadine ophthalmic solution) is a topical H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.

Development History and FDA Approval Process for Lastacaft

Jul 28, 2010Approval FDA Approves Lastacaft (alcaftadine ophthalmic solution) for Prevention of Itching Associated with Allergic Conjunctivitis

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.